The METTL3 inhibitor STM2457 suppresses gastric cancer progression by modulating m6A RNA modification.
Saved in:
| Title: | The METTL3 inhibitor STM2457 suppresses gastric cancer progression by modulating m6A RNA modification. |
|---|---|
| Authors: | Sun, Hang1 (AUTHOR), Xu, Haozhi1,2 (AUTHOR), Li, Junying3 (AUTHOR), Xie, Xiaoman1 (AUTHOR), Zhang, Junmei1 (AUTHOR), Dong, Hongjie1 (AUTHOR), Xie, Huanhuan1 (AUTHOR), Wang, Qi1 (AUTHOR), Zhao, Guihua1 (AUTHOR), Yin, Kun1 (AUTHOR), Yang, Jingyu2 (AUTHOR), Zhou, Jianwei4 (AUTHOR) immunolife@126.com, Wu, Ruili2 (AUTHOR) wrl3602@hotmail.com, Xu, Chao1 (AUTHOR) xu0927@hotmail.com |
| Source: | PLoS ONE. 3/24/2026, Vol. 21 Issue 3, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
